BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 153 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2020. The put-call ratio across all filers is 6.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,468,000 | +4.4% | 473,550 | +21.6% | 0.00% | – |
| Q3 2021 | $1,406,000 | +10.1% | 389,564 | +9.1% | 0.00% | – |
| Q2 2021 | $1,277,000 | -21.8% | 356,933 | -14.6% | 0.00% | – |
| Q1 2021 | $1,634,000 | -10.4% | 417,894 | -3.7% | 0.00% | – |
| Q4 2020 | $1,823,000 | +43.3% | 434,064 | +27.2% | 0.00% | – |
| Q3 2020 | $1,272,000 | -15.8% | 341,136 | -1.5% | 0.00% | – |
| Q2 2020 | $1,510,000 | +21.1% | 346,205 | +5.2% | 0.00% | – |
| Q1 2020 | $1,247,000 | -56.8% | 329,153 | -28.0% | 0.00% | -100.0% |
| Q4 2019 | $2,889,000 | +217.8% | 457,183 | +111.7% | 0.00% | – |
| Q3 2019 | $909,000 | -45.9% | 215,978 | -40.2% | 0.00% | – |
| Q2 2019 | $1,680,000 | +62.3% | 361,198 | +85.0% | 0.00% | – |
| Q1 2019 | $1,035,000 | +531.1% | 195,264 | +341.0% | 0.00% | – |
| Q4 2018 | $164,000 | +32.3% | 44,280 | 0.0% | 0.00% | – |
| Q3 2018 | $124,000 | -5.3% | 44,280 | -0.0% | 0.00% | – |
| Q2 2018 | $131,000 | +10.1% | 44,281 | -15.7% | 0.00% | – |
| Q1 2018 | $119,000 | -9.8% | 52,559 | +17.7% | 0.00% | – |
| Q4 2017 | $132,000 | +0.8% | 44,668 | +0.9% | 0.00% | – |
| Q3 2017 | $131,000 | +5.6% | 44,280 | 0.0% | 0.00% | – |
| Q2 2017 | $124,000 | +47.6% | 44,280 | 0.0% | 0.00% | – |
| Q1 2017 | $84,000 | +7.7% | 44,280 | -0.7% | 0.00% | – |
| Q4 2016 | $78,000 | -54.1% | 44,594 | -29.2% | 0.00% | – |
| Q3 2016 | $170,000 | +25.9% | 62,945 | +9.9% | 0.00% | – |
| Q2 2016 | $135,000 | -81.8% | 57,268 | -75.0% | 0.00% | – |
| Q1 2016 | $741,000 | -27.6% | 229,404 | +7.3% | 0.00% | – |
| Q4 2015 | $1,024,000 | -37.6% | 213,726 | -27.5% | 0.00% | -100.0% |
| Q3 2015 | $1,640,000 | -39.1% | 294,925 | -12.8% | 0.00% | 0.0% |
| Q2 2015 | $2,693,000 | -71.6% | 338,307 | -62.5% | 0.00% | -50.0% |
| Q1 2015 | $9,471,000 | -13.1% | 902,035 | -0.5% | 0.00% | -33.3% |
| Q4 2014 | $10,898,000 | -34.3% | 906,580 | -6.5% | 0.00% | -25.0% |
| Q3 2014 | $16,578,000 | -18.4% | 970,059 | -42.4% | 0.00% | +33.3% |
| Q2 2014 | $20,320,000 | +747.0% | 1,683,508 | +492.2% | 0.00% | +200.0% |
| Q1 2014 | $2,399,000 | +189.4% | 284,303 | +102.2% | 0.00% | – |
| Q4 2013 | $829,000 | -52.6% | 140,616 | -56.3% | 0.00% | – |
| Q3 2013 | $1,748,000 | +213.8% | 321,932 | +134.5% | 0.00% | – |
| Q2 2013 | $557,000 | – | 137,261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |